- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05977686
Hemoglobin Testing in Pregnant Patients (Prosp Anemia)
Point-of-Care Hemoglobin Testing in Pregnant Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a prospective, observational study for which aim to recruit 200 patients over the study period. Patients will be approached at one of the MFA Obstetrics and Gynecology clinics. Once consented, they will be approached at least two time-points during their antenatal care as below:
- OB new/ first prenatal visit (usually between 12-18 weeks of gestation)
- OB return visit (usually between 24-28 weeks of gestation)
May need to get more Hb time-points readings (up to five readings) if the patient will be diagnosed with anemia at any of the previously mentioned visits or will be scheduled to have more blood draws during the prenatal care period. At each time-point visit, we plan to talk with the provider of the patient about the study. Then the study protocol and the recruitment process with the patient will be discussed. If the patient consents, the researchers will coordinate with the lab personnel the exact time of the routinely ordered blood draw (as a part of the subject's antenatal care) to determine the appropriate time to get the Hb readings using the devices (preferrably, right before the venipuncture). To obtain the readings, a study research coordinator will apply a disposable probe (Rainbow R1 25 adult adhesive sensor) connected to a Radical-7 co-oximeter sensor on the ring finger of the same arm of the venipuncture, shielded by an opaque covering to eliminate intereference from ambient light to obtain the SpHb reading. In addition, during in the same setting, we will ask for a finger prick capillary sample to get the Hemocue Hb reading as well (the same side will be used). Both readings will be tabulated in a case report form and the standard lab hemoglobin reading will be added to them once received. This is how it will validate the performance of the Masimo and the Hemocue devices with the routine lab test results. Additionally, the researchers will collect demographics, procedure-specific and some antenatal-care variables including vitals, gestational age and the exact date and time of the records at each time point visit, using a well-structured case report form.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jaclyn Phillips, MD
- Phone Number: 2027412500
- Email: japhillips@mfa.gwu.edu
Study Contact Backup
- Name: Homa Ahmadzia, MD/MPH
- Phone Number: 2027412500
- Email: hahmadzia@mfa.gwu.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant women ages 18-50 years old
Exclusion Criteria:
- Patients with hemoglobinopathies (qualitative defects, sickle-cell anemia) and hemoglobin synthesis disorders (quantitative defects such as thalassemia)
- Patients with peripheral vascular diseases and skin conditions that affect blood vessels in the digit
- Patients with hyperbilirubinemia
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Accuracy of the devices in all obstetric patients
Time Frame: 2024
|
2024
|
Ability of point-of-care hemoglobin testing devices to detect anemia (Hemoglobin less than 11 mg/dL) or severe anemia (Hemoglobin less than 9 mg/dL).
Time Frame: 2024
|
2024
|
Subgroup analysis: by gestational age categories presence or absence of anemia as defined by the gold standard venipuncture
Time Frame: 2024
|
2024
|
Patient perception of testing methods
Time Frame: 2024
|
2024
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCR234874
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Partum Hemorrhage
-
Yariv yogevRabin Medical CenterUnknownPost-Partum Hemorrhage
-
Laboratoire français de Fractionnement et de BiotechnologiesCompleted
-
Hackensack Meridian HealthCompletedPost-partum Hemorrhage (PPH)United States
-
Tampere University HospitalCompletedBlood Transfusion | Post-partum HemorrhageFinland
-
University Hospital, MontpellierNot yet recruitingPost Partum Haemorrhage
-
Oxytone Bioscience BVTerminatedPost Partum HaemorrhageSweden
-
North Bristol NHS TrustFerring Pharmaceuticals; University of Bristol; University Hospitals Bristol... and other collaboratorsCompleted
-
Qazvin University Of Medical SciencesCompletedPost Partum HaemorrhageIran, Islamic Republic of
-
University of BirminghamKing's College London; University College, London; University of Nairobi; World... and other collaboratorsCompletedPost-Partum HaemorrhageSouth Africa, Kenya, Tanzania, Nigeria
-
Hospices Civils de LyonUnknownPost Partum HaemorrhageFrance
Clinical Trials on Masimo Root Radical 7 Pulse CO-Oximeter
-
Trakya UniversityCompletedPerfusion Index | One-Lung Ventilation | Hypoxemia During Surgery | Oxygen Reserve Index | Pleth Variability IndexTurkey
-
Pamela PetersenCompleted
-
Cairo UniversityCompletedCongenital Heart DiseaseEgypt
-
Samsun Education and Research HospitalCompleted
-
Children's Hospital of PhiladelphiaChildren's Anesthesiology Associates, Ltd.CompletedScoliosis | Spinal FusionUnited States
-
Cairo UniversityAbdelhamid, Bassant Mohamed, M.D.; Mohamed, Ahmed A., M.D.; Ashraf Mohamed Abd... and other collaboratorsCompletedMasimo Radical Pulse Co-oximeter in Intraoperative Blood Transfusion Practice During Obestatric ProcedureEgypt
-
George Washington UniversityActive, not recruiting
-
Antalya Training and Research HospitalCompletedCesarean Section ComplicationsTurkey
-
Kasr El Aini HospitalUnknownAntepartum Hemorrhage
-
Zonguldak Bulent Ecevit UniversityCompletedFresh Flow | CarboxyhemoglobinemiaTurkey